Loading…
Prospective evaluation of prognostic factors in operable breast cancer
In 215 patients with operable breast cancer (T1-T3, N0-1, M0) and no other or previous cancer, presenting to a single breast unit, sufficient tumour was available for the prospective determination of four putative biochemical markers of prognosis: oestrogen receptor (ER) activity, cathepsin D (cath...
Saved in:
Published in: | British journal of cancer 1996-11, Vol.74 (9), p.1469-1478 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c435t-d3a8637d0eea3cb0a836e04c6632ec88a7971875e6b9b9ebf3c32f4e3f49b7953 |
---|---|
cites | |
container_end_page | 1478 |
container_issue | 9 |
container_start_page | 1469 |
container_title | British journal of cancer |
container_volume | 74 |
creator | HAWKINS, R. A TESDALE, A. L KILLEN, M. E JACK, W. J. L CHETTY, U DIXON, J. M HULME, M. J PRESCOTT, R. J MCINTYRE, M. A MILLER, W. R |
description | In 215 patients with operable breast cancer (T1-T3, N0-1, M0) and no other or previous cancer, presenting to a single breast unit, sufficient tumour was available for the prospective determination of four putative biochemical markers of prognosis: oestrogen receptor (ER) activity, cathepsin D (cath D), epidermal growth factor receptor (EGFR) activity and cyclic AMP-binding proteins (c-AMP-b). There were significant inter-relationships between ER and EGFR (r = -0.26), c-AMP-b and cath D (r = +0.32) and ER and c-AMP-b (r = +0.14). After follow-up (median 36.2 months), a total of 55 recurrences (18 locoregional only) and 35 deaths were recorded. By univariate analysis, up to 10 of 18 biochemical, clinical and histopathological variables of potential prognostic value were significantly related to disease-free interval or death, but by multivariate analysis only oestrogen receptor concentration and node status contributed significantly to risk of both distant recurrence/death; in addition, tumour size made a small contribution to the risk for a distant recurrence only. Only two parameters, tumour grade and ER concentration, were significantly related to risk of locoregional recurrence by univariate analysis, but by multivariate analysis, only tumour grade was important. It is concluded that tumour ER concentration, axillary nodal status and tumour grade remain as the most important prognostic factors in the early years after presentation of operable breast cancer, with a minor influence of tumour size. At this time, the prognostic significance of quantitative measurements of ER concentration, carefully controlled for the quality of both assay and tumour specimen, is probably greater than is generally appreciated. We have yet to identify other factors, which add significantly to the short-term prognostic value of these key features. |
doi_str_mv | 10.1038/bjc.1996.567 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2074769</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78526770</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-d3a8637d0eea3cb0a836e04c6632ec88a7971875e6b9b9ebf3c32f4e3f49b7953</originalsourceid><addsrcrecordid>eNpVkM9rFDEYhkNR2rXtrdfCHMSTs2aSya-LUIpVoaAHPYcv2W_alNnJNMks-N-bZZdFT-HjfXjf8BBy09F1R7n-5F78ujNGroVUZ2TVCc7aTjP1hqwopaqlhtEL8i7nl3oaqtU5OdemY6JXK_LwM8U8oy9hhw3uYFyghDg1cWjmFJ-mmEvwzQC-xJSbUIMZE7gRG5cQcmk8TB7TFXk7wJjx-vhekt8PX37df2sff3z9fn_32Pqei9JuOGjJ1YYiAveOguYSae-l5Ay91qCM6rQSKJ1xBt3APWdDj3zojVNG8Evy-dA7L26LG49TSTDaOYUtpD82QrD_J1N4tk9xZxlVvZKmFnw4FqT4umAudhuyx3GECeOSrdKCSaVoBT8eQF8F5YTDaaSjdu_dVu92791W7xW__fdjJ_gouubvjzlkD-OQqraQTxhnQkjBK9YcsAnKkvCU16391H7pL32ImAc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78526770</pqid></control><display><type>article</type><title>Prospective evaluation of prognostic factors in operable breast cancer</title><source>PubMed Central</source><creator>HAWKINS, R. A ; TESDALE, A. L ; KILLEN, M. E ; JACK, W. J. L ; CHETTY, U ; DIXON, J. M ; HULME, M. J ; PRESCOTT, R. J ; MCINTYRE, M. A ; MILLER, W. R</creator><creatorcontrib>HAWKINS, R. A ; TESDALE, A. L ; KILLEN, M. E ; JACK, W. J. L ; CHETTY, U ; DIXON, J. M ; HULME, M. J ; PRESCOTT, R. J ; MCINTYRE, M. A ; MILLER, W. R</creatorcontrib><description>In 215 patients with operable breast cancer (T1-T3, N0-1, M0) and no other or previous cancer, presenting to a single breast unit, sufficient tumour was available for the prospective determination of four putative biochemical markers of prognosis: oestrogen receptor (ER) activity, cathepsin D (cath D), epidermal growth factor receptor (EGFR) activity and cyclic AMP-binding proteins (c-AMP-b). There were significant inter-relationships between ER and EGFR (r = -0.26), c-AMP-b and cath D (r = +0.32) and ER and c-AMP-b (r = +0.14). After follow-up (median 36.2 months), a total of 55 recurrences (18 locoregional only) and 35 deaths were recorded. By univariate analysis, up to 10 of 18 biochemical, clinical and histopathological variables of potential prognostic value were significantly related to disease-free interval or death, but by multivariate analysis only oestrogen receptor concentration and node status contributed significantly to risk of both distant recurrence/death; in addition, tumour size made a small contribution to the risk for a distant recurrence only. Only two parameters, tumour grade and ER concentration, were significantly related to risk of locoregional recurrence by univariate analysis, but by multivariate analysis, only tumour grade was important. It is concluded that tumour ER concentration, axillary nodal status and tumour grade remain as the most important prognostic factors in the early years after presentation of operable breast cancer, with a minor influence of tumour size. At this time, the prognostic significance of quantitative measurements of ER concentration, carefully controlled for the quality of both assay and tumour specimen, is probably greater than is generally appreciated. We have yet to identify other factors, which add significantly to the short-term prognostic value of these key features.</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/bjc.1996.567</identifier><identifier>PMID: 8912547</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>Basingstoke: Nature Publishing Group</publisher><subject>Age Factors ; Analysis of Variance ; Biological and medical sciences ; Biomarkers, Tumor - analysis ; Breast Neoplasms - chemistry ; Breast Neoplasms - pathology ; Breast Neoplasms - surgery ; Carrier Proteins ; Cathepsin D - analysis ; Cyclic AMP Receptor Protein - analysis ; ErbB Receptors - analysis ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Mammary gland diseases ; Medical sciences ; Middle Aged ; Neoplasm Recurrence, Local ; Prognosis ; Proportional Hazards Models ; Prospective Studies ; Receptors, Estrogen - analysis ; Survival Analysis ; Tumors</subject><ispartof>British journal of cancer, 1996-11, Vol.74 (9), p.1469-1478</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-d3a8637d0eea3cb0a836e04c6632ec88a7971875e6b9b9ebf3c32f4e3f49b7953</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074769/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074769/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3255653$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8912547$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HAWKINS, R. A</creatorcontrib><creatorcontrib>TESDALE, A. L</creatorcontrib><creatorcontrib>KILLEN, M. E</creatorcontrib><creatorcontrib>JACK, W. J. L</creatorcontrib><creatorcontrib>CHETTY, U</creatorcontrib><creatorcontrib>DIXON, J. M</creatorcontrib><creatorcontrib>HULME, M. J</creatorcontrib><creatorcontrib>PRESCOTT, R. J</creatorcontrib><creatorcontrib>MCINTYRE, M. A</creatorcontrib><creatorcontrib>MILLER, W. R</creatorcontrib><title>Prospective evaluation of prognostic factors in operable breast cancer</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><description>In 215 patients with operable breast cancer (T1-T3, N0-1, M0) and no other or previous cancer, presenting to a single breast unit, sufficient tumour was available for the prospective determination of four putative biochemical markers of prognosis: oestrogen receptor (ER) activity, cathepsin D (cath D), epidermal growth factor receptor (EGFR) activity and cyclic AMP-binding proteins (c-AMP-b). There were significant inter-relationships between ER and EGFR (r = -0.26), c-AMP-b and cath D (r = +0.32) and ER and c-AMP-b (r = +0.14). After follow-up (median 36.2 months), a total of 55 recurrences (18 locoregional only) and 35 deaths were recorded. By univariate analysis, up to 10 of 18 biochemical, clinical and histopathological variables of potential prognostic value were significantly related to disease-free interval or death, but by multivariate analysis only oestrogen receptor concentration and node status contributed significantly to risk of both distant recurrence/death; in addition, tumour size made a small contribution to the risk for a distant recurrence only. Only two parameters, tumour grade and ER concentration, were significantly related to risk of locoregional recurrence by univariate analysis, but by multivariate analysis, only tumour grade was important. It is concluded that tumour ER concentration, axillary nodal status and tumour grade remain as the most important prognostic factors in the early years after presentation of operable breast cancer, with a minor influence of tumour size. At this time, the prognostic significance of quantitative measurements of ER concentration, carefully controlled for the quality of both assay and tumour specimen, is probably greater than is generally appreciated. We have yet to identify other factors, which add significantly to the short-term prognostic value of these key features.</description><subject>Age Factors</subject><subject>Analysis of Variance</subject><subject>Biological and medical sciences</subject><subject>Biomarkers, Tumor - analysis</subject><subject>Breast Neoplasms - chemistry</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - surgery</subject><subject>Carrier Proteins</subject><subject>Cathepsin D - analysis</subject><subject>Cyclic AMP Receptor Protein - analysis</subject><subject>ErbB Receptors - analysis</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Mammary gland diseases</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local</subject><subject>Prognosis</subject><subject>Proportional Hazards Models</subject><subject>Prospective Studies</subject><subject>Receptors, Estrogen - analysis</subject><subject>Survival Analysis</subject><subject>Tumors</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNpVkM9rFDEYhkNR2rXtrdfCHMSTs2aSya-LUIpVoaAHPYcv2W_alNnJNMks-N-bZZdFT-HjfXjf8BBy09F1R7n-5F78ujNGroVUZ2TVCc7aTjP1hqwopaqlhtEL8i7nl3oaqtU5OdemY6JXK_LwM8U8oy9hhw3uYFyghDg1cWjmFJ-mmEvwzQC-xJSbUIMZE7gRG5cQcmk8TB7TFXk7wJjx-vhekt8PX37df2sff3z9fn_32Pqei9JuOGjJ1YYiAveOguYSae-l5Ay91qCM6rQSKJ1xBt3APWdDj3zojVNG8Evy-dA7L26LG49TSTDaOYUtpD82QrD_J1N4tk9xZxlVvZKmFnw4FqT4umAudhuyx3GECeOSrdKCSaVoBT8eQF8F5YTDaaSjdu_dVu92791W7xW__fdjJ_gouubvjzlkD-OQqraQTxhnQkjBK9YcsAnKkvCU16391H7pL32ImAc</recordid><startdate>19961101</startdate><enddate>19961101</enddate><creator>HAWKINS, R. A</creator><creator>TESDALE, A. L</creator><creator>KILLEN, M. E</creator><creator>JACK, W. J. L</creator><creator>CHETTY, U</creator><creator>DIXON, J. M</creator><creator>HULME, M. J</creator><creator>PRESCOTT, R. J</creator><creator>MCINTYRE, M. A</creator><creator>MILLER, W. R</creator><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19961101</creationdate><title>Prospective evaluation of prognostic factors in operable breast cancer</title><author>HAWKINS, R. A ; TESDALE, A. L ; KILLEN, M. E ; JACK, W. J. L ; CHETTY, U ; DIXON, J. M ; HULME, M. J ; PRESCOTT, R. J ; MCINTYRE, M. A ; MILLER, W. R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-d3a8637d0eea3cb0a836e04c6632ec88a7971875e6b9b9ebf3c32f4e3f49b7953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Age Factors</topic><topic>Analysis of Variance</topic><topic>Biological and medical sciences</topic><topic>Biomarkers, Tumor - analysis</topic><topic>Breast Neoplasms - chemistry</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - surgery</topic><topic>Carrier Proteins</topic><topic>Cathepsin D - analysis</topic><topic>Cyclic AMP Receptor Protein - analysis</topic><topic>ErbB Receptors - analysis</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Mammary gland diseases</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local</topic><topic>Prognosis</topic><topic>Proportional Hazards Models</topic><topic>Prospective Studies</topic><topic>Receptors, Estrogen - analysis</topic><topic>Survival Analysis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HAWKINS, R. A</creatorcontrib><creatorcontrib>TESDALE, A. L</creatorcontrib><creatorcontrib>KILLEN, M. E</creatorcontrib><creatorcontrib>JACK, W. J. L</creatorcontrib><creatorcontrib>CHETTY, U</creatorcontrib><creatorcontrib>DIXON, J. M</creatorcontrib><creatorcontrib>HULME, M. J</creatorcontrib><creatorcontrib>PRESCOTT, R. J</creatorcontrib><creatorcontrib>MCINTYRE, M. A</creatorcontrib><creatorcontrib>MILLER, W. R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HAWKINS, R. A</au><au>TESDALE, A. L</au><au>KILLEN, M. E</au><au>JACK, W. J. L</au><au>CHETTY, U</au><au>DIXON, J. M</au><au>HULME, M. J</au><au>PRESCOTT, R. J</au><au>MCINTYRE, M. A</au><au>MILLER, W. R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prospective evaluation of prognostic factors in operable breast cancer</atitle><jtitle>British journal of cancer</jtitle><addtitle>Br J Cancer</addtitle><date>1996-11-01</date><risdate>1996</risdate><volume>74</volume><issue>9</issue><spage>1469</spage><epage>1478</epage><pages>1469-1478</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><coden>BJCAAI</coden><abstract>In 215 patients with operable breast cancer (T1-T3, N0-1, M0) and no other or previous cancer, presenting to a single breast unit, sufficient tumour was available for the prospective determination of four putative biochemical markers of prognosis: oestrogen receptor (ER) activity, cathepsin D (cath D), epidermal growth factor receptor (EGFR) activity and cyclic AMP-binding proteins (c-AMP-b). There were significant inter-relationships between ER and EGFR (r = -0.26), c-AMP-b and cath D (r = +0.32) and ER and c-AMP-b (r = +0.14). After follow-up (median 36.2 months), a total of 55 recurrences (18 locoregional only) and 35 deaths were recorded. By univariate analysis, up to 10 of 18 biochemical, clinical and histopathological variables of potential prognostic value were significantly related to disease-free interval or death, but by multivariate analysis only oestrogen receptor concentration and node status contributed significantly to risk of both distant recurrence/death; in addition, tumour size made a small contribution to the risk for a distant recurrence only. Only two parameters, tumour grade and ER concentration, were significantly related to risk of locoregional recurrence by univariate analysis, but by multivariate analysis, only tumour grade was important. It is concluded that tumour ER concentration, axillary nodal status and tumour grade remain as the most important prognostic factors in the early years after presentation of operable breast cancer, with a minor influence of tumour size. At this time, the prognostic significance of quantitative measurements of ER concentration, carefully controlled for the quality of both assay and tumour specimen, is probably greater than is generally appreciated. We have yet to identify other factors, which add significantly to the short-term prognostic value of these key features.</abstract><cop>Basingstoke</cop><pub>Nature Publishing Group</pub><pmid>8912547</pmid><doi>10.1038/bjc.1996.567</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-0920 |
ispartof | British journal of cancer, 1996-11, Vol.74 (9), p.1469-1478 |
issn | 0007-0920 1532-1827 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2074769 |
source | PubMed Central |
subjects | Age Factors Analysis of Variance Biological and medical sciences Biomarkers, Tumor - analysis Breast Neoplasms - chemistry Breast Neoplasms - pathology Breast Neoplasms - surgery Carrier Proteins Cathepsin D - analysis Cyclic AMP Receptor Protein - analysis ErbB Receptors - analysis Female Gynecology. Andrology. Obstetrics Humans Mammary gland diseases Medical sciences Middle Aged Neoplasm Recurrence, Local Prognosis Proportional Hazards Models Prospective Studies Receptors, Estrogen - analysis Survival Analysis Tumors |
title | Prospective evaluation of prognostic factors in operable breast cancer |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A26%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prospective%20evaluation%20of%20prognostic%20factors%20in%20operable%20breast%20cancer&rft.jtitle=British%20journal%20of%20cancer&rft.au=HAWKINS,%20R.%20A&rft.date=1996-11-01&rft.volume=74&rft.issue=9&rft.spage=1469&rft.epage=1478&rft.pages=1469-1478&rft.issn=0007-0920&rft.eissn=1532-1827&rft.coden=BJCAAI&rft_id=info:doi/10.1038/bjc.1996.567&rft_dat=%3Cproquest_pubme%3E78526770%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c435t-d3a8637d0eea3cb0a836e04c6632ec88a7971875e6b9b9ebf3c32f4e3f49b7953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78526770&rft_id=info:pmid/8912547&rfr_iscdi=true |